IMS Health IPO Could Value Company At Up To $6.97 Billion

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IMS Health Holdings Inc, backed by TPG Capital Management LP TPG.UL, said it expected to price its initial public offering at $18-$21 per share, valuing the healthcare information company at up to $6.97 billion. The company said the sale of 65 million shares was expected to raise about $1.36 billion, based on the top end of the price range. IMS said it would sell 52 million shares in the offering, with the rest being offered by shareholders.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC